Sanofi SA SNY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:24 PM EDT
49.27quote price arrow down-0.27 (-0.55%)
Volume
810,352
52 week range
42.63 - 57.82
Loading...
  • Open49.25
  • Day High49.44
  • Day Low49.10
  • Prev Close49.54
  • 52 Week High57.82
  • 52 Week High Date04/26/23
  • 52 Week Low42.63
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap124.642B
  • Shares Out2.53B
  • 10 Day Average Volume1.86M
  • Dividend2.04
  • Dividend Yield4.14%
  • Beta0.61
  • YTD % Change-1.06

KEY STATS

  • Open49.25
  • Day High49.44
  • Day Low49.10
  • Prev Close49.54
  • 52 Week High57.82
  • 52 Week High Date04/26/23
  • 52 Week Low42.63
  • 52 Week Low Date10/27/23
  • Market Cap124.642B
  • Shares Out2.53B
  • 10 Day Average Volume1.86M
  • Dividend2.04
  • Dividend Yield4.14%
  • Beta0.61
  • YTD % Change-1.06

RATIOS/PROFITABILITY

  • EPS (TTM)2.37
  • P/E (TTM)20.77
  • Fwd P/E (NTM)5.90
  • EBITDA (TTM)16.438B
  • ROE (TTM)7.26%
  • Revenue (TTM)50.28B
  • Gross Margin (TTM)69.35%
  • Net Margin (TTM)11.95%
  • Debt To Equity (MRQ)24.88%

EVENTS

  • Earnings Date04/25/2024(est)
  • Ex Div Date05/09/2024
  • Div Amount2.0374
  • Split Date-
  • Split Factor-

Latest On Sanofi SA

 

Profile

MORE
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment...
Frederic Oudea
Independent Chairman of the Board
Paul Hudson Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Roy Papatheodorou
Executive Vice President, General Counsel, Member of the Executive Committee
Brendan O'Callaghan
Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee
Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Address
46 Avenue de la Grande Armee
Paris
75017
France

Top Peers

SYMBOLLASTCHG%CHG
BMY
Bristol-Myers Squibb Co
54.13+0.88+1.65%
GSK
GSK plc
43.20+0.21+0.49%
PFE
Pfizer Inc
27.90+0.12+0.43%
AMGN
Amgen Inc
285.96-0.34-0.12%
GILD
Gilead Sciences Inc
73.55+0.53+0.73%